Login Register Cart 0
Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Piperonal: The Journey so Far

Author(s): Jain Akash, Chaudhary Dushyant and Chaudhary Jasmine*

Volume 20, Issue 18, 2020

Page: [1846 - 1856] Pages: 11

DOI: 10.2174/1389557520666200711173149

Price: $65

Abstract

Piperonal, an important aromatic aldehyde containing the benzene ring fused to 1, 3- dioxolane moiety, widely occurred in nature and known for its fragrance similar to vanillin and cherry. Alterations in its structural features led to the access of a wide range of piperonal derivatives viz. pyrazolines, chalcones, benzothiazepines, benzoxazoles, triazoles etc. having remarkable pharmacological properties like antimicrobial, anticancer, antidiabetic, antitubercular activities, etc. Therefore, the present study has been designed to highlight the progress made in the area of piperonal and its derivatives till date with respect to their synthesis and pharmacological activities. This may facilitate the synthesis of more novel derivatives with improved biological activities. Various search engines like google, Pubmed, Scopus etc. were used to gather the related information using different keywords.

Keywords: Piperonal, biological, activity, derivatives, pharmacological, synthesis.

« Previous Next »
Graphical Abstract

[1]
Katritzky, A.R.; Karelson, M.; Malhotra, N. Heterocyclic aromaticity. Heterocycles, 1991, 32, 127.
[http://dx.doi.org/10.3987/REV-90-420]
[2]
Mulla, A.A. Biological importance of heterocyclic compounds. Pharma Chem., 2017, 9(13), 141-147.
[3]
Arora, P.; Arora, V.; Lamba, H.S.; Wadhwa, D. Importance of heterocyclic chemistry: a review. IJPSR, 2012, 3(9), 2947-2954.
[4]
Dhanasekar, M.; Sridevi, G.; Arul, A.S.; Angayarkani, R. A recent review in applications of heterocyclic compounds as antimicrobial agent. Asian J Pharm Clin Res., 2018, 11(12), 66.
[http://dx.doi.org/10.22159/ajpcr.2018.v11i12.26890]
[5]
Asif, M. Anticonvulsant activities of various series of heterocyclic compounds containing triazole, thiadiazine, benzo-triazole, benzothiazole, oxadiazole ring systems. AJCOC, 2015, 1, 1-23.
[6]
Martins, P.; Jesus, J.; Santos, S.; Raposo, L.R.; Roma-Rodrigues, C.; Baptista, P.V.; Fernandes, A.R. Heterocyclic anticancer compounds: Recent advances and the paradigm shift towards the use of nanomedicine’s tool box. Molecules, 2015, 20(9), 16852-16891.
[http://dx.doi.org/10.3390/molecules200916852] [PMID: 26389876]
[7]
Tsolaki, E.; Nobelos, P.; Geronikaki, A.; Rekka, E.A. Selected heterocyclic compounds as antioxidants. Synthesis and biological evaluation. Curr. Top. Med. Chem., 2014, 14(22), 2462-2477.
[http://dx.doi.org/10.2174/1568026614666141203120425] [PMID: 25478888]
[8]
Asif, M. A brief overview on recent advances in the development of anti-tubercular compounds containing different heterocyclic ring systems. Appli Micro., 2016, 2(4), 1-14.
[http://dx.doi.org/10.4172/2471-9315.1000122]
[9]
Dhingra, A.K.; Chopra, B.; Dua, J.S.; Prasad, D.N. Therapeutic potential of N-heterocyclic analogs as anti-inflammatory agents. Antiinflamm. Antiallergy Agents Med. Chem., 2017, 16(3), 136-152.
[http://dx.doi.org/10.2174/1871523017666180126150901] [PMID: 29376495]
[10]
Wang, S.; Chen, D. Solubility of piperonal in different pure solvents and binary isopropanol and water solvent mixtures. Korean J. Chem. Eng., 2006, 23(6), 1034-1036.
[http://dx.doi.org/10.1007/s11814-006-0026-y]
[11]
Ru, J.; Li, P.; Wang, J.; Zhou, W.; Li, B.; Huang, C.; Li, P.; Guo, Z.; Tao, W.; Yang, Y.; Xu, X.; Li, Y.; Wang, Y.; Yang, L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform., 2014, 6(1), 13.
[http://dx.doi.org/10.1186/1758-2946-6-13] [PMID: 24735618]
[12]
Gnadinger, C.B. Piperonal in Vanilla extract. Ind. Eng. Chem., 1926, 18(6), 588-589.
[http://dx.doi.org/10.1021/ie50198a014]
[13]
Fahlbusch, K.G.; Hammerschmidt, F.G.; Panten, J.; Pickenhagen, W.; Schatkowski, D.; Bauer, K.; Garbe, D.; Surburg, H. Flavors and Fragrances.Ullmann’s Encyclopedia of Industrial Chemistry; Wiley-VCH: Weinheim, Germany, 2003.
[http://dx.doi.org/10.1002/14356007.a11_141]
[14]
de Souza Tavares, W.; Akhtar, Y.; Gonçalves, G.L.P.; Zanuncio, J.C.; Isman, M.B. Turmeric powder and its derivatives from Curcuma longa rhizomes: Insecticidal effects on cabbage looper and the role of synergists. Sci. Rep., 2016, 6, 34093.
[http://dx.doi.org/10.1038/srep34093] [PMID: 27804972]
[15]
Fernando, C.S.; Eliseo, A.M.; Cortes, M.T.; Marco, F.S. Study of the electrochemical oxidation process of 3,4-(methylenedioxy) phenylmethanol in non-aqueous solvents. J. Electroanal. Chem. (Lausanne Switz.), 2007, 606(1), 1-7.
[http://dx.doi.org/10.1016/j.jelechem.2007.04.003]
[16]
Bjorsvik, H.R.; Liguori, L.; Minisci, F. High selectivity in the oxidation of mandelic acid derivatives and in o-methylation of protocatechualdehyde: New processes for synthesis of vanillin, iso-vanillin, and heliotropin. Org. Process Res. Dev., 2000, 4(6), 534-543.
[http://dx.doi.org/10.1021/op0000529]
[17]
Nwaukwa, S.O.; Keehn, P.M. Oxidative cleavage of α-diols, α-diones, α-hydroxy-ketones and α-hydroxy- and α-keto acids with calcium hypochlorite. Tetrahedron Lett., 1982, 23(31), 3135-3138. [Ca(OCl)2
[http://dx.doi.org/10.1016/S0040-4039(00)88578-0]
[18]
A. Process for the preparation of heliotropin. GB 1538214, 1979 10 Jan;
[19]
Grimshaw, J.; Hua, C. The conversion of isosafrole to piperonal and anethole to anisaldehyde: Electrochemical active manganese dioxide. Electrochim. Acta, 1994, 39(4), 497-499.
[http://dx.doi.org/10.1016/0013-4686(94)80092-8]
[20]
Mathew, A.; Sheeja, T.L.M.; Kumar, T.A.; Radha, K. Design, synthesis and biological evaluation of pyrazole analogues of natural piperine. Hygeia J D Med., 2011, 3(2), 48-56.
[21]
Bellardita, M.; Vittorio, L.; Giovanni, P.; Ivana, P.; Leonardo, P.; Vincenzo, A. Photocatalytic green synthesis of piperonal in aqueous TiO2 suspension. Appl. Catal. B, 2014, 144, 607-613.
[http://dx.doi.org/10.1016/j.apcatb.2013.07.070]
[22]
Lucarelli, C.; Lolli, A.; Giugni, A.; Grazia, L.; Albonetti, S.; Monticelli, D.; Vaccarib, A. Efficient and ecofriendly route for the solvent-free synthesis of piperonal and aromatic aldehydes using Au/CeO2catalyst. Appl. Catal. B, 2017, 203, 314-323.
[http://dx.doi.org/10.1016/j.apcatb.2016.10.030]
[23]
Lange, R.J. Cleavage of alkyl o-hydroxyphenyl ethers. J. Org. Chem., 1962, 27, 2037-2039.
[http://dx.doi.org/10.1021/jo01053a030]
[24]
Toloza, A.C.; Zygadlo, J.; Cueto, G.M.; Biurrun, F.; Zerba, E.; Picollo, M.I. Fumigant and repellent properties of essential oils and component compounds against permethrin-resistant Pediculus humanus capitis (Anoplura: Pediculidae) from Argentina. J. Med. Entomol, 2006, 43(5), 889-895.
[http://dx.doi.org/10.1603/0022-2585(2006)43[889:FARPOE]2.0.CO;2] [PMID: 17017225]
[25]
Toloza, A.C.; Zygadlo, J.; Mougabure-Cueto, G.; Zerba, E.; Faillaci, S.; Picollo, M.I. The fumigant and repellent activity of aliphatic lactones against Pediculus humanus capitis (Anoplura: Pediculidae). Mem. Inst. Oswaldo Cruz, 2006, 101(1), 55-56.
[http://dx.doi.org/10.1590/S0074-02762006000100010] [PMID: 16699710]
[26]
Alvarez, H.M.; Barbosa, D.P.; Fricks, A.T.; Aranda, D.A.G.; Valdes, R.H.; Antunes, O.A.C. Production of piperonal, vanillin, and p-anisaldehyde via solventless supported iodobenzene diacetate oxidation of isosafrol, isoeugenol, and anethol under microwave irradiation. Org. Process Res. Dev., 2006, 10(5), 941-943.
[http://dx.doi.org/10.1021/op060117t]
[27]
Abdullah, A.A.; Hussain, M.S.M.M. Synthesis and evaluation of piperonal chalcone and its derivatives as anti-diabetic agents. EJBPS, 2018, 5(2), 514-518.
[28]
Li, X.; Choi, Y.; Yanakawa, Y.; Park, T. Piperonal prevents high-fat diet-induced hepatic steatosis and insulin resistance in mice via activation of adiponectin/AMPK pathway. Int. J. Obes., 2014, 38(1), 140-147.
[http://dx.doi.org/10.1038/ijo.2013.70] [PMID: 23711775]
[29]
Rogers, C.Q.; Ajmo, J.M.; You, M. Adiponectin and alcoholic fatty liver disease. IUBMB Life, 2008, 60(12), 790-797.
[http://dx.doi.org/10.1002/iub.124] [PMID: 18709650]
[30]
Redd, W.H.; Manne, S.L.; Peters, B.; Jacobsen, P.B.; Schmidt, H. Fragrance administration to reduce anxiety during MR imaging. J. Magn. Reson. Imaging, 1994, 4(4), 623-626.
[http://dx.doi.org/10.1002/jmri.1880040419] [PMID: 7949692]
[31]
Sheeja, M.; Mathew, A.; Varkey, J. Design, synthesis and pharmacological evaluation of isoxazole analogues derived from natural piperine. Asian J Pharm Health Sci., 2012, 2(1), 256-260.
[32]
Pei, Y.Q.; Yue, W.; Cui, J.R.; Yao, H.Y. A study of the central pharmacological action of piperine and its derivatives. Yao Xue Xue Bao, 1980, 15(4), 198-205.
[PMID: 7457138]
[33]
Pei, Y.Q. A review of pharmacology and clinical use of piperine and its derivatives. Epilepsia, 1983, 24(2), 177-182.
[http://dx.doi.org/10.1111/j.1528-1157.1983.tb04877.x] [PMID: 6832079]
[34]
Mori, A.; Kabuto, H.; Pei, Y.Q. Effects of piperine on convulsions and on brain serotonin and catecholamine levels in E1 mice. Neurochem. Res., 1985, 10(9), 1269-1275.
[http://dx.doi.org/10.1007/BF00964845] [PMID: 4058659]
[35]
D’Hooge, R.; Pei, Y.Q.; Raes, A.; Lebrun, P.; van Bogaert, P.P.; de Deyn, P.P. Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists. Arzneimittelforschung, 1996, 46(6), 557-560.
[PMID: 8767343]
[36]
Aukunuru, J.; Keerthana, E.; Venkanna, P.; Venumadhav, K.; Srinivas, R.K. Synthesis of novel piperonal derivatives and evaluation of their anticonvulsant activity using a nanoparticular formulation. IJPSN, 2009, 2(1), 435-432.
[37]
Kaveeshwar, S.A.; Cornwall, J. The current state of diabetes mellitus in India. Australas. Med. J., 2014, 7(1), 45-48.
[http://dx.doi.org/10.4066/AMJ.2014.1979] [PMID: 24567766]
[38]
Hsieh, C.T.; Hsieh, T.J.; El-Shazly, M.; Chuang, D.W.; Tsai, Y.H.; Yen, C.T.; Wu, S.F.; Wu, Y.C.; Chang, F.R. Synthesis of chalcone derivatives as potential anti-diabetic agents. Bioorg. Med. Chem. Lett., 2012, 22(12), 3912-3915.
[http://dx.doi.org/10.1016/j.bmcl.2012.04.108] [PMID: 22608392]
[39]
Rocha, S.; Ribeiro, D.; Fernandes, E.; Freitas, M. Systematic review on anti-diabetic properties of chalcones. Curr. Med. Chem., 2018.
[http://dx.doi.org/10.2174/0929867325666181001112226] [PMID: 30277140]
[40]
Nammi, S.; Koka, S.; Chinnala, K.M.; Boini, K.M. Obesity: an overview on its current perspectives and treatment options. Nutr. J., 2004, 3, 3.
[http://dx.doi.org/10.1186/1475-2891-3-3] [PMID: 15084221]
[41]
Selmaoui, B. Obesity and the biological clock: A New Paradigm? J Clin Mol Endocrinol., 2016.1e103
[42]
Kumar, D.R.S.; Rohith, M.; Philip, G. A study on prevalence of overweight and obesity amongst school children of Bangalore. Int J Community Med Public Health., 2019, 6(1), 159-163.
[http://dx.doi.org/10.18203/2394-6040.ijcmph20185236]
[43]
Meriga, B.; Parim, B.; Chunduri, V.R.; Naik, R.R.; Nemani, H.; Suresh, P.; Ganapathy, S.; Sathibabu Uddandrao, V.V. Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats. Nutr. Metab. (Lond.), 2017, 14, 72.
[http://dx.doi.org/10.1186/s12986-017-0228-9] [PMID: 29176994]
[44]
Ali, I.; Wani, W.A.; Kishwar, S. Cancer scenario in India with future perspectives. Cancer Ther., 2011, 8, 56-70.
[45]
Sahoo, S.S.; Verma, M.; Parija, P.P. An overview of cancer registration in India: Present status and future challenges. Oncol J India., 2018, 2, 86-89.
[http://dx.doi.org/10.4103/oji.oji_40_18]
[46]
Kidwai, M.; Venkataramanan, R.; Mohan, R.; Sapra, P. Cancer chemotherapy and heterocyclic compounds. Curr. Med. Chem., 2002, 9(12), 1209-1228.
[http://dx.doi.org/10.2174/0929867023370059] [PMID: 12052173]
[47]
Ali, I.; Lone, M.N.; Al-Othman, Z.A.; Al-Warthan, A.; Sanagi, M.M. Heterocyclic scaffolds: Centrality in anticancer drug development. Curr. Drug Targets, 2015, 16(7), 711-734.
[http://dx.doi.org/10.2174/1389450116666150309115922] [PMID: 25751009]
[48]
Sharma, R.; Kumar, R.; Kodwani, R.; Kapoor, S.; Khare, A.; Bansal, R.; Khurana, S.; Singh, S.; Thomas, J.; Roy, B.; Phartyal, R.; Saluja, S.; Kumar, S. A review on mechanisms of anti tumor activity of chalcones. Anticancer. Agents Med. Chem., 2015, 16(2), 200-211.
[http://dx.doi.org/10.2174/1871520615666150518093144] [PMID: 25980813]
[49]
Das, M.; Manna, K. Chalcone scaffold in anticancer armamentarium: A molecular insight. J. Toxicol., 2016.20167651047
[http://dx.doi.org/10.1155/2016/7651047] [PMID: 26880913]
[50]
Zhou, H.; Cheng, J.Q.; Wang, Z.S.; Chen, F.H.; Liu, X.H. Oxazole: A promising building block for the development of potent antitumor agents. Curr. Top. Med. Chem., 2016, 16(30), 3582-3589.
[http://dx.doi.org/10.2174/1568026616666160414122521] [PMID: 27086791]
[51]
Liu, J.J.; Zhao, M.Y.; Zhang, X.; Zhao, X.; Zhu, H.L. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents. Mini Rev. Med. Chem., 2013, 13(13), 1957-1966.
[http://dx.doi.org/10.2174/13895575113139990078] [PMID: 23937232]
[52]
Ardiansah, B. Recent reports on pyrazole-based bioactive compounds as candidate for anticancer agent. Asian J Pharm Clin Res., 2017, 10(12), 45-51.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i12.22065]
[53]
Fadda, A.A.; Ehab, A.L.; Tawfik, E.H.; Mohammed, R.M. Synthesis of some new benzoxazole derivatives and their cytotoxicity to human cancer cell lines. RJPBCS, 2016, 7(1), 1820-1826.
[54]
Anwar, P.; Bobby, S.P. Design, docking study and ADME prediction of chalcone derivatives as potent tubulin inhibitors. J. Comput. Aided Mol. Des., 2014, 4(1), 1-5.
[55]
Thomas, S.; Markus, B. Use of piperonal as an anti-inflammatory additive to cosmetics and medicaments. European Patent EP0997137, 2002 May;
[56]
Sandhu, G.K. Tuberculosis: current situation, challenges and overview of its control programs in India. J. Glob. Infect. Dis., 2011, 3(2), 143-150.
[http://dx.doi.org/10.4103/0974-777X.81691] [PMID: 21731301]
[57]
Fernandes, G.F.D.S.; Man Chin, C.; Dos Santos, J.L. Advances in drug discovery of new antitubercular multidrug-resistant compounds. Pharmaceuticals (Basel), 2017, 10(2), 51.
[http://dx.doi.org/10.3390/ph10020051] [PMID: 28587160]
[58]
Khurana, A.K.; Dhingra, B. What is new in management of pediatric tuberculosis? Indian Pediatr., 2019, 56(3), 213-220.
[http://dx.doi.org/10.1007/s13312-019-1503-9] [PMID: 30954994]
[59]
Ahmad, A.; Husain, A.; Khan, S.A.; Mujeeb, M.; Bhandari, A. Synthesis, antimicrobial and antitubercular activities of some novel pyrazoline derivatives. J. Saudi Chem. Soc., 2016, 20(5), 577-584.
[http://dx.doi.org/10.1016/j.jscs.2014.12.004]
[60]
Soni, H.M.; Patel, P.K.; Chhabria, M.T.; Patel, A.K.; Rana, D.N.; Brahmkshatriya, P.S. Design, synthesis and biological evaluation of novel antitubercular agents by combining pyrazoline and benzoxazole pharmacophores. Int. J. Org. Chem. (Irvine), 2016, 6, 157-176.
[http://dx.doi.org/10.4236/ijoc.2016.63017]
[61]
Bhat, K.I.; Kumar, A. Pyrimidines as potent cytotoxic and anti-inflammatory agents. Asian J Pharm Clin Res., 2017, 10(6), 1-4.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i4.14334]
[62]
Bhutani, R.; Pathak, D.P.; Husain, A.; Kapoor, G.; Kant, R. A review on recent development of pyrazoline as a pharmacologically active molecule. IJPSR, 2015, 6(10), 4113-4128.
[63]
Deshpande, S.R.; Nagrale, S.N.; Patil, M.V.; Chavan, P.S. Novel 3,4-methylenedioxybenzene scaffold incorporated 1,3,5-Trisubstituted-2-pyrazolines: Synthesis, characterization and evaluation for chemotherapeutic activity. Indian J. Pharm. Sci., 2015, 77(1), 24-33.
[http://dx.doi.org/10.4103/0250-474X.151588] [PMID: 25767315]
[64]
Aslam, B.; Wang, W.; Arshad, M.I.; Khurshid, M.; Muzammil, S.; Rasool, M.H.; Nisar, M.A.; Alvi, R.F.; Aslam, M.A.; Qamar, M.U.; Salamat, M.K.F.; Baloch, Z. Antibiotic resistance: a rundown of a global crisis. Infect. Drug Resist., 2018, 11, 1645-1658.
[http://dx.doi.org/10.2147/IDR.S173867] [PMID: 30349322]
[65]
Dua, R.; Shrivastava, S.; Sonwane, S.K.; Srivastava, S.K. Pharmacological significance of synthetic heterocycles scaffold: A review. Adv. Biol. Res. (Faisalabad), 2011, 5(3), 120-144.
[66]
Desai, N.; Trivedi, A.; Pandit, U.; Dodiya, A.; Rao, V.K.; Desai, P. Hybrid bioactive heterocycles as potential antimicrobial agents: A review. Mini Rev. Med. Chem., 2016, 16(18), 1500-1526.
[http://dx.doi.org/10.2174/1389557516666160609075620] [PMID: 27292782]
[67]
Sharma, P.K. A review: antimicrobial agents based on nitrogen and sulfur containing heterocycles. Asian J Pharm Clin Res., 2017, 10(2), 47-49.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i2.15673]
[68]
Sharma, P.K.; Kaur, G. A review on antimicrobial activities of important thiazines based heterocycles. Drug Invent Today., 2017, 9(3), 23-25.
[69]
Bajod, S.S. Synthesis and biological screening of some heterocycles derived from piperonal. Acta Chim Pharm Indica., 2013, 3(4), 261-267.
[70]
Vidhya, K.R.; Shafi, S.S. Synthesis, characterization and antimicrobial studies of novel 2-pyrazoline derivatives. Int. J. Chemtech Res., 2014, 6(4), 2558-2563.
[71]
Kadhum, M.Y.; Abduljleel, A.M. Synthesis, characterization and biological studies of schiff bases derived from piperonal and their complexes with cobalt (II). Pharma Chem., 2014, 6(5), 88-100.
[72]
Neto, J.B.A.; Silva, C.R.; Campos, R.S.; Nascimento, F.B.S.A.; Freitas, D.D.; Josino, M.A.A.; Andrade, L.N.D.; Goncalves, T.B.; Mesquita, J.R.L.; Magalhaes, H.I.F.; Rodrigues, F.A.R.; Gaspar, D.M.; Moraes, M.O.; Lobo, M.D.P.; Frederico, F.B.M.B.; Grangeiro, T.B.; Gomes, A.O.C.V.; Nascente, L.C.N.; Romeiro, L.A.S.; Cavalcanti, B.C.; Junior, H.V.N. Effects of piperonal nitro derivatives on Candida species: Antifungal activity against fluconazole-resistant strains is associated with oxidative DNA damage. Int. J. Curr. Microbiol. Appl. Sci., 2015, 4(4), 777-792.
[73]
Srinivas, A.; Sunitha, M. Synthesis of piperonyl triazoles as antimicrobial agents. Indian J Chem., 2016, 55(B), 102-109.
[74]
Dimas, S.; Ismiyarto, I.; Ngadiwiyana, N. Synthesis and antibacterial testing of imine derivative compounds from piperonal and aniline. Jurnal Kimia Sains dan Aplikasi., 2018, 21(1), 44-48.
[75]
Karamunge, K.G.M.; Vibhute, A.Y.; Vibhute, Y.B. Synthesis of some new chalcones, pyrazolines and acetyl pyrazolines derived from piperonal and halogenohydroxy acetophenones as antimicrobial agents. J. Indian Chem. Soc., 2011, 88, 443.
[76]
Burgess, I.F.; Brown, C.M.; Burgess, N.A.; Kaufman, J. Can head louse repellents really work? Field studies of piperonal 2% spray. PeerJ, 2014.2e351
[http://dx.doi.org/10.7717/peerj.351] [PMID: 24765585]
[77]
Bowles, B.L.; Miller, A.J. Antibotulinal properties of selected aromatic and aliphatic aldehydes. J. Food Prot., 1993, 56(9), 788-794.
[http://dx.doi.org/10.4315/0362-028X-56.9.788] [PMID: 31113058]
[78]
Lüthy, I.A.; Bruzzone, A.; Piñero, C.P.; Castillo, L.F.; Chiesa, I.J.; Vázquez, S.M.; Sarappa, M.G. Adrenoceptors: non conventional target for breast cancer? Curr. Med. Chem., 2009, 16(15), 1850-1862.
[http://dx.doi.org/10.2174/092986709788186048] [PMID: 19442150]
[79]
Geidl, W.; Pfeifer, K. Physical activity and exercise for rehabilitation of type 2 diabetes. Rehabilitation (Stuttg.), 2011, 50(4), 255-265.
[http://dx.doi.org/10.1055/s-0031-1280805] [PMID: 21800269]
[80]
Zolghadri, S.; Bahrami, A.; Hassan Khan, M.T.; Munoz-Munoz, J.; Garcia-Molina, F.; Garcia-Canovas, F.; Saboury, A.A. A comprehensive review on tyrosinase inhibitors. J. Enzyme Inhib. Med. Chem., 2019, 34(1), 279-309.
[http://dx.doi.org/10.1080/14756366.2018.1545767] [PMID: 30734608]
[81]
Lopes, N.D.; Chaves, O.A.; de Oliveira, M.C.C.; Sant’Anna, C.M.R.; Sousa-Pereira, D.; Netto-Ferreira, J.C.; Echevarria, A. Novel piperonal 1,3,4-thiadiazolium-2-phenylamines mesoionic derivatives: Synthesis, tyrosinase inhibition evaluation and HSA binding study. Int. J. Biol. Macromol., 2018, 112, 1062-1072.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.02.050] [PMID: 29447969]

Rights & Permissions Print Cite
Article Metrics
28
1
© 2024 Bentham Science Publishers | Privacy Policy